4WM
GILD icon

44 Wealth Management’s Gilead Sciences GILD Stock Holding History

44 Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Sell
1,860
-118
-6% -$15.5K 0.08% 176
2026
Q1 		$276K Sell
1,978
-956
-33% -$134K 0.1% 168
2025
Q4 		$360K Buy
2,934
+12
+0.4% +$1.46K 0.12% 160
2025
Q3 		$324K Sell
2,922
-1
-0% -$114 0.11% 173
2025
Q2 		$324K Buy
2,923
+105
+4% +$11.2K 0.11% 169
2025
Q1 		$316K Sell
2,818
-127
-4% -$13.1K 0.12% 164
2024
Q4 		$272K Sell
2,945
-216
-7% -$19.4K 0.1% 173
2024
Q3 		$276K Buy
+3,161
New +$241K 0.1% 174
2023
Q2 		$262K Sell
3,395
-44
-1% -$3.51K 0.09% 149
2023
Q1 		$285K Sell
3,439
-79
-2% -$6.54K 0.1% 147
2022
Q4 		$302K Sell
3,518
-6
-0.2% -$475 0.1% 144
2022
Q3 		$217K Sell
3,524
-527
-13% -$33.2K 0.09% 156
2022
Q2 		$250K Sell
4,051
-811
-17% -$50.2K 0.1% 147
2022
Q1 		$289K Buy
4,862
+839
+21% +$53.6K 0.1% 145
2021
Q4 		$292K Buy
4,023
+873
+28% +$60.1K 0.1% 149
2021
Q3 		$220K Sell
3,150
-163
-5% -$11.5K 0.08% 159
2021
Q2 		$228K Buy
+3,313
New +$221K 0.09% 161

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

44 Wealth Management's GILD Position: Q2 2026 in Review

44 Wealth Management reduced its Gilead Sciences (GILD) stake by 6% in Q2 2026, selling an estimated $15.5K and leaving 1,860 shares worth $235K. The position accounts for 0.08% of the portfolio, ranked #176.

44 Wealth Management first reported a position in GILD in Q2 2021 and has held it in 17 quarters since. The position peaked at $360K in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • 44 Wealth Management held 1,860 shares of Gilead Sciences worth $235K as of Q2 2026.
  • 44 Wealth Management sold 118 Gilead Sciences shares in Q2 2026, an estimated $15.5K.
  • Gilead Sciences made up 0.08% of 44 Wealth Management's portfolio in Q2 2026, its #176 holding.
  • 44 Wealth Management first reported a position in Gilead Sciences in Q2 2021 and has held it in 17 quarters since.
  • 44 Wealth Management's Gilead Sciences position peaked at $360K in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on 44 Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.